학술논문

Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study
Document Type
Article
Source
In: CPT: Pharmacometrics and Systems Pharmacology. (CPT: Pharmacometrics and Systems Pharmacology, June 2024, 13(6):1055-1066)
Subject
Language
English
ISSN
21638306